Home › NCT06178744
A Study of AI in Cardiac Transplant in Echocardiographic Analysis (ORACLE)
Outcome Reflection for Immune Mediated Rejection by Utilizing Artificial Intelligence in Cardiac Transplant Patients Through Early and Late Echocardiographic Analysis (ORACLE)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients undergoing post-cardiac transplant endomyocardial biopsy, and the ability to provide informed consent and a consent for the study. Exclusion Criteria: * Refusal of study participation
About the study
The purpose of this research is to detect episodes of rejection versus non-rejection after cardiac transplant and the diagnostic accuracy of an Artificial Intelligence (AI) algorithm using the data from an ECG (electrocardiogram) and Cardiac Ultrasound (Echocardiogram and/or point of care ultrasound).
Sponsor: Mayo Clinic · Participants: 500 · Started: Apr 4, 2024
Contact the study team
- Alyssa Lokensgard · Phone: 507-422-5123
- Atta Behfar, MD, PhD · Phone: 507-266-0318
Official record on ClinicalTrials.gov — NCT06178744
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.